Pharmacokinetics of rifabutin.
We investigated the pharmacokinetics of rifabutin in 15 male patients as part of a phase I trial of the treatment of early symptomatic human immunodeficiency virus infection. Six or more patients were studied at each of four different oral dosage levels: 300, 600, 900, and 1,200 mg/day. Twelve studi...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1989
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2552902/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1237 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|